Introduction
============

Lung function is an important indicator of respiratory health and long-term survival ([@r23]). Unlike information collected through questionnaires, measured lung function is an objective health outcome that is not affected by recall or reporting bias. The respiratory tract is at risk from air pollution, because gaseous pollutants and small particles in the air are inhaled through the nose and mouth. Two air pollutants frequently studied are nitrogen dioxide (NO~2~) and particulate matter (PM). Both are derived from traffic related sources, but are also generated within the home---for example, by gas cookers and cigarette smoke. Both of these pollutants have been associated with respiratory and cardiovascular morbidity and mortality ([@r6]). Several cross-sectional and longitudinal studies have been carried out on the association between NO~2~ and PM exposure and lung function in children. However, results of these studies have been disparate and conclusions inconsistent. Whereas some studies reported associations with lung volume only ([@r40]; [@r41]; [@r47]), others reported associations with expiratory flow only ([@r2]; [@r36]). Some studies reported associations with both lung volume and flow ([@r18]; [@r24]; [@r42]), whereas others reported no associations at all ([@r17]; [@r22]; [@r33]; [@r34]). In a recent review of studies on air pollution and lung function, [@r20] concluded that it was not possible to perform formal quantitative comparisons of findings because of the heterogeneity of study designs.

One limitation common to many previous studies lies in the assessment of exposure to air pollution. Most studies of the effects of air pollution on lung development in children have estimated associations with more recent air pollution exposure---the average concentration over the previous 12 months, rather than lifetime exposure or early-life exposure ([@r36]), and have estimated exposures based on measurements from central monitoring stations located near the child's residence, without accounting for geographical factors ([@r22]; [@r34]; [@r36]), indoor as well as outdoor exposures, or time--activity patterns.

We have developed a novel microenvironmental exposure model (MEEM) ([@r32]), which allows for spatial (indoor and outdoor microenvironments) and temporal variability in pollutant concentrations ([@r30], [@r31]) and incorporates children's time--activity patterns to predict personal exposure. The performance of MEEM (for NO~2~) was evaluated previously through a personal monitoring study of 46 12- to 13-year-old schoolchildren in Manchester, United Kingdom ([@r32]); we found good agreement between modeled and measured NO~2~ concentration (e.g., mean predictor error = --0.75; normalized mean bias factor = 0.04; normalized mean average error factor = 0.27; Spearman's rank correlation = 0.31, *p* \< 0.05) This performance evaluation also demonstrated that MEEM provided better estimates of exposure than central monitors or an outdoor air pollution model, which tended to overestimate personal exposure levels ([@r32]).

The aim of the present study was to estimate the associations of modeled PM~10~ (particulate matter with an aerodynamic diameter ≤ 10 μm) and NO~2~ exposure with lung function in elementary-school children enrolled in a population-based birth cohort---the Manchester Asthma and Allergy Study (MAAS). Exposures and lung function were evaluated longitudinally throughout childhood. In addition, we applied a more detailed exposure model in a cross-sectional analysis of lung function measured at 11 years of age.

Methods
=======

*Study population.* The children studied were participants of MAAS, is an ongoing prospective birth cohort, which initially comprised 1,185 children of mothers who were recruited during pregnancy at two local hospitals between 1995 and 1997 ([@r43]). Children attended review clinics at ages 3, 5, 8, and 11 years; the clinics included pulmonary function tests and skin prick tests for common inhalant and food allergens. In addition, parentally completed questionnaires were collected at each review ([@r11], [@r10]). MAAS received ethical approval by the Local Research Ethics Committee (SOU/00/258; SOU/00/259), and written informed consent was provided by the parents.

*Definition of outcomes: lung function.* All pulmonary function tests were performed by trained technicians at Wythenshawe Hospital, Manchester. The most informative test to measure lung function was selected for each age group ([@r4]; [@r5]; [@r12]).

Specific airways resistance (sR~aw~) was measured at ages 3, 5, 8, and 11 years, using a constant volume whole-body plethysmograph (Masterscreen Body 4.3; Erich Jaeger GmbH, Würzburg, Germany) ([@r28]; [@r35]). High values of sR~aw~ indicate poor lung function. Forced expiratory volume in 1 sec (FEV~1~) was measured at ages 5, 8, and 11 years using a pneumotachograph-based spirometer (Erich Jaeger Gmbh). The protocol for measuring FEV~1~ was in accordance with American Thoracic Society guidelines ([@r1]). All children were asymptomatic at the time of testing, and β2-agonists were withheld for at least 4 hr before testing. The test was repeated at intervals of 30 sec until three technically acceptable traces were obtained, the highest two of which were within 5% of each other. The percent predicted FEV~1~ was calculated using reference equations developed by the Asthma UK Collaborative Initiative ([@r44]). Postbronchodilator FEV~1~ was measured when the children were 5 and 11 years of age by repeating the FEV~1~ measurement 15 min after inhalation of 400 μg of albuterol. Results were analyzed as percent predicted FEV~1~.

*Definition of exposures: modeled PM~10~ and NO~2~ exposure.* The exposure estimates in this study are based on the concept of microenvironments (ME)---a defined space with a homogenous pollutant concentration ([@r37]). MEs can represent spaces outdoors or indoors, and different methods can be used to estimate concentrations in different types of microenvironments. The microenvironmental models used in this study assumed that children spend the majority of their time in three types of MEs: home, school, and the journey between home and school.

Information on children's home and school addresses from birth to 11 years of age was collected through a parental questionnaire, completed at the age 11 review. In this questionnaire parents were asked to list the dates and addresses for all homes the child had lived in and each school the child attended, the mode of transport between each home and respective schools. These data were entered into an SQL database (MS SQL2008R2; Microsoft, Redmond, WA, USA) to create a timeline for home and school addresses from birth to 11 years of age for each child. In addition, the shortest driving route between each home and school was estimated using the network analyst extension of ArcGIS9.2 (ESRI, Redlands, CA, USA).

[Figure 1](#f1){ref-type="fig"} summarizes the methods used to estimate NO~2~ and PM~10~ concentration in each ME. Concentrations for outdoor MEs (i.e., home outdoor ME, school outdoor ME, journey outdoor ME) were estimated using land use regression (LUR) models, as described in detail elsewhere ([@r30], [@r31]). In brief, LUR models were developed using estimated annual mean NO~2~ and PM~10~ concentrations at 208 locations derived from an air dispersion model. The final LUR models mainly comprised traffic-related predictor variables, such as vehicle counts on major roads, and had determination coefficients (*R*^2^) of 0.71. Performance evaluations using a set-aside data set (70 locations), and concentrations measured at automatic monitoring stations showed an acceptable level of agreement (*R*^2^ range, 0.33--0.86). To model children's exposure from 1996 through 2008, the above LUR models were recalibrated to provide 13 annual models for PM~10~ and NO~2~, respectively ([@r31]): Data from the air dispersion model and the United Kingdom year adjustment calculator were used to estimate annual PM~10~ and NO~2~ concentrations from 1996 through 2008 at the 278 receptor sites described above. These concentrations were entered into regression analyses that included the same predictor variables used in the original LUR models. This resulted in individual models for each year; all models used the same predictor variables but generated different coefficients. A performance evaluation of these models against monitored data showed good agreement \[*R*^2^ range, 0.35--0.97; root mean square error (RMSE) range, 1.8--8.3\] ([@r31]).

![Outline of exposure assessment showing methods used to estimate concentrations in each microenvironment (with relevant references). The same methods were used at all time points except for the year before the age 11 review. A detailed indoor model could be used to estimate concentrations inside the kitchen, living room, and child's bedroom. Abbreviations: I/O, Indoor to outdoor ratio; MEEM, micro­environmental exposure model.](ehp.1205961.g001){#f1}

Concentrations for journey indoor MEs (i.e., inside cars or buses) and school indoor MEs were estimated based on indoor to outdoor (I/O) ratios published in the literature ([@r26]; [@r46]). Concentrations in the Home indoor MEs were estimated using I/O ratios or a mass balance model (INDAIR), depending on the time period being modeled ([@r16]). This resulted in two slightly different models: the MEEM and the lifetime models ([Figure 1](#f1){ref-type="fig"}).

MEEM was used to estimate each child's exposures during the summer and winter before the review visit at 11 years of age ([@r32]). We modeled winter and summer exposures separately to capture variation in home indoor air concentrations because of seasonal differences in air exchange rates. In MEEM home kitchen ME, home living room ME, and home bedroom ME, concentrations were estimated individually using the INDAIR model, designed specifically to estimate indoor concentrations of NO~2~ and PM~10~ concentrations within residential buildings in the United Kingdom ([@r15], [@r16]).

A parent questionnaire administered at the child's age 11 review was used to collect input parameters for the INDAIR model, such as room sizes, air exchange rates, and the presence of indoor sources of NO~2~ and PM~10~. The indoor sources included in the model were gas cooking and cigarette smoke, which are considered to be the main sources of NO~2~ and PM~10~ inside homes in the United Kingdom ([@r3]; [@r9]). In addition, the questionnaire collected time--activity data used to estimate the timing and duration of time in each ME. Therefore, MEEM provided spatially resolved time-weighted exposure estimates for each child.

We evaluated the performance of MEEM using a personal monitoring study of schoolchildren (12--13 years of age) attending a local secondary school in Manchester ([@r32]). MEEM performed well when compared with NO~2~ concentrations measured with personal monitors (Ogawa passive samplers; Ogawa & Co. USA, Inc., Pompano Beach, FL, USA), with a mean prediction error of --0.75 μg/m^3^. A paired analysis of measured and predicted concentrations showed no significant difference between measured concentrations and MEEM estimates (Wilcoxon's signed rank test: *z* = --0.05, *p* = 0.96).

Input parameters for the INDAIR model were available for the current (at 11 years of age) home of each child, but most children had changed residence at least once since birth. Therefore, we used a simplified lifetime model to estimate the average PM~10~ and NO~2~ exposure of each child for each month from birth to 11 years. In contrast with MEEM, the lifetime model used an I/O ratio to calculate exposure inside the home, instead of using the INDAIR model, and it assumed that all children were in the school indoor ME from 0900 to 1500 hours. However, as for MEEM, outdoor ME exposures (i.e., home outdoor ME, school outdoor ME, journey outdoor ME) were estimated using LUR models, and journey indoor MEs (i.e., inside cars or buses) and school indoor MEs were estimated based on I/O ratios.

*Definition of potential confounders.* Potential confounding variables and covariates were identified based on previous research within MAAS and previous publications ([@r28], [@r29]; [@r35]; [@r36]) and included sex, age, ethnicity, older siblings, sensitization, asthma or current wheeze, family history of asthma, parental smoking, parental atopy, child care attendance during the first 2 years of life, hospitalization during the first 2 years of life, presence of a gas cooker in the home, presence of a dog or cat in the home, visible signs of dampness or mold in the home, body height, body weight, body mass index, maternal age at birth, gestational age, duration of breastfeeding, Tanner stage (age 11 years only), and socioeconomic status (paternal income). In addition, average PM~10~ and NO~2~ concentrations over 3 days before the child's review visit were collected from four (for PM~10~) or five (for NO~2~) urban background monitoring stations across the Greater Manchester area ([@r36]).

We classified children as having current wheeze based on a positive response to the question "Has your child had wheezing or whistling in the chest in the last 12 months?" and classified them as having asthma based on positive answers to at least two of the following three variables: doctor diagnosis of asthma ever; current wheeze; asthma medication during the previous 12 months, consistent with the GA^2^LEN (Global Allergy and Asthma European Network) definition of asthma ([@r8]; [@r21]). At each review, potential allergic sensitization to common inhalant and food allergens was determined through skin prick tests for inhalant allergens (mites, cat, dog, mold, grass pollen, and tree pollen) and food allergens (milk, egg, and peanut). All allergens were tested at each review except for tree pollen and peanut allergens, which were tested at the age 8 and age 11 reviews only. Children were classified as having atopy, if they had at least one positive skin prick test (defined as a mean wheal diameter 3 mm greater than the negative control). Parental atopy was also established through skin prick tests, which were carried out during the recruitment stage.

*Statistical analysis.* All analyses were carried out with SPSS 16.0 (IBM SPSS, Chicago, IL, USA). Before all analyses, sR~aw~ was ln-transformed because it follows a log-normal distribution. FEV~1~ and postbronchodilator FEV~1~ were not transformed because these variables were normally distributed. Multivariable linear regression was used to cross-sectionally estimate associations of PM~10~ and NO~2~ exposure during the summer and winter before children were 11 years of age (estimated by MEEM), with sR~aw~ and FEV~1~ at 11 years. All potential confounders were entered individually into bivariate models with the exposure and outcome variables, and potential confounders that were significant predictors of the outcome (*p* \< 0.05) were evaluated using multivariate stepwise analyses that retained only covariates that significantly predicted the outcome, or that were retained *a priori* (age and sex in all sR~aw~ models, Tanner stage for all models of outcomes at age 11). Models of FEV~1~ outcomes were not adjusted for age, sex, and body height, because these factors were used to calculate the percent predicted values. Models of MEEM exposures at 11 years of age were not adjusted for cigarette smoking because information on smoking was already included in the INDAIR model.

We analyzed the association between lifetime exposure and the development of lung function using generalized estimating equations to account for the within-subject correlation of repeated measures, with the same covariates included in the cross-sectional models. Monthly exposures were averaged into the following time windows: for sR~aw~, 0--3, 3--5, 5--8, and 5--11 years of age; for FEV~1~, 0--5, 5--8, and 8--11 years of age; for FEV~1~ after bronchodilator treatment, 0--5 and 5--11 years of age. For completeness, exposure estimates from the lifetime exposure model were also analyzed cross-sectionally against lung function at 3, 5, 8, and 11 years of age. For these analyses the monthly exposure estimates were averaged into the following time windows: first year of life (0--1), birth to review ages (0--3, 0--5, 0--8, 0--11 years), 1 calendar year before reviews (2--3, 4--5, 7--8, 10--11 years). The level for statistical significance was set at *p* \< 0.05.

Results
=======

*Participants and descriptive data.* Participant flow with numbers of individuals at each stage of the study, the number of lung function measurements collected and the number of exposure estimates available is shown in [Figure 2](#f2){ref-type="fig"}. Descriptive statistics of the study population and the covariates included in the final models are presented in [Table 1](#t1){ref-type="table"}; descriptive statistics of potential confounders not included in the final models are shown in Supplemental Material, Table S1. As expected, the prevalence of atopy increased from 3 to 11 years of age, whereas the prevalence of asthma or current wheeze remained fairly constant during this time period. A complete data set of FEV~1~, pollutant exposures, and covariates at two or more reviews was available for 342 children ([Table 1](#t1){ref-type="table"}). Children included in the longitudinal analysis of the effect of PM~10~ and NO~2~ exposure on the change in FEV~1~ were more likely to be female and were less likely to have asthma or wheeze in early life. By 8 years of age, there were no differences in asthma/wheeze between children with full sets of longitudinal data and those without. [Table 2](#t2){ref-type="table"} summarizes the lung function measurements at each age. The mean FEV~1~ increased from 1.05 L at 5 years to 2.30 L at 11 years, resembling typical values for Caucasian children of these ages ([@r44]).

![Flow diagram of MAAS cohort showing participation rates at each review, the number of lung function measurements collected, and the number of exposure estimates available.](ehp.1205961.g002){#f2}

###### 

Description of study population.

  Variable                                                                                                                                                                                                                                                                                                                                                                                         MAAS cohort at birth   Children with longitudinal FEV~1~ and longitudinal exposure data   *p-*Value^*c*^                
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------- ------------------------------------------------------------------ ---------------- ------------ -------
  Female sex                                                                                                                                                                                                                                                                                                                                                                                       1,185                  543 (45.8)                                                         342              173 (50.6)   0.036
  Family history of asthma                                                                                                                                                                                                                                                                                                                                                                         1,185                  441 (37.2)                                                         342              125 (36.5)   0.763
  Child is atopic^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Age 3                                                                                                                                                                                                                                                                                                                                                                                            983                    225 (22.9)                                                         306              72 (23.5)    0.748
  Age 5                                                                                                                                                                                                                                                                                                                                                                                            963                    294 (30.5)                                                         334              94 (28.1)    0.241
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            927                    314 (33.9)                                                         330              100 (30.3)   0.088
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           784                    281 (35.8)                                                         332              116 (34.9)   0.652
  Child has asthma or current wheeze                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Age 3                                                                                                                                                                                                                                                                                                                                                                                            1,097                  296 (27.0)                                                         330              71 (21.5)    0.007
  Age 5                                                                                                                                                                                                                                                                                                                                                                                            1,071                  297 (27.7)                                                         341              75 (22.0)    0.004
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            1,023                  217 (21.2)                                                         341              65 (19.1)    0.234
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           925                    214 (23.1)                                                         341              78 (22.9)    0.886
  Hospitalization during first 2 years of life for lower respiratory tract infection                                                                                                                                                                                                                                                                                                               1,185                  109 (9.2)                                                          342              34 (9.9)     0.573
  Gas cooker in the home                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Age 1                                                                                                                                                                                                                                                                                                                                                                                            1,028                  801 (77.9)                                                         341              270 (79.2)   0.492
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            1,029                  819 (79.6)                                                         342              270 (78.9)   0.717
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           930                    727 (78.2)                                                         342              267 (78.1)   0.954
  Age at follow-up (years)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Age 3                                                                                                                                                                                                                                                                                                                                                                                            1,081                  3.0 ± 0.1                                                          326              3.0 ± 0.0    0.208
  Age 5                                                                                                                                                                                                                                                                                                                                                                                            1,044                  5.0 ± 0.1                                                          340              5.0 ± 0.1    0.008
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            976                    8.0 ± 0.2                                                          339              8.0 ± 0.1    0.084
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           813                    11.4 ± 0.5                                                         341              11.4 ± 0.5   0.876
  Body mass index (kg/m²)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Age 3                                                                                                                                                                                                                                                                                                                                                                                            1,044                  16.7 ± 1.4                                                         321              16.7 ± 1.5   0.914
  Age 5                                                                                                                                                                                                                                                                                                                                                                                            1,017                  16.3 ± 1.6                                                         339              16.4 ± 1.7   0.776
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            923                    17.1 ± 2.4                                                         333              17.1 ± 2.6   0.643
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           816                    19.1 ± 3.4                                                         341              19.2 ± 3.4   0.885
  Short-term PM~10~ (μg/m^3^) 3-day average before review visit                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Age 3                                                                                                                                                                                                                                                                                                                                                                                            1,081                  21.6 ± 7.7                                                         326              21.0 ± 6.9   0.186
  Age 5                                                                                                                                                                                                                                                                                                                                                                                            1,044                  21.5 ± 7.2                                                         340              21.6 ± 7.2   0.910
  Age 8                                                                                                                                                                                                                                                                                                                                                                                            976                    20.8 ± 6.2                                                         339              21.0 ± 6.0   0.660
  Age 11                                                                                                                                                                                                                                                                                                                                                                                           820                    19.6 ± 9.2                                                         337              19.7 ± 9.0   0.895
  Mean Tanner stage                                                                                                                                                                                                                                                                                                                                                                                763                    2.1 ± 0.9                                                          317              2.1 ± 0.9    0.648
  ^***a***^Total number of children. ^***b***^Number of positive children. ^***c***^*p*-Value of chi-square test or Student's *t*-test comparing children with longitudinal FEV~1~ and exposure data against all children in the MAAS cohort at birth. ^***d***^Determined through skin prick test, mean wheal diameter 3 mm greater than negative control for at least 1 of 9 allergens tested.                                                                                                                           

###### 

Summary of lung function measures at each review (mean ± SD).

  Lung function measure                     Age 3         Age 5          Age 8         Age 11
  ----------------------------------------- ------------- -------------- ------------- --------------
  sR~aw~ (kPa/sec)^*a*^                     1.10 (1.23)   1.17 (1.21)    1.22 (1.23)   1.26 (1.29)
  FEV~1~ (L)                                              1.05 ± 0.16    1.59 ± 0.25   2.30 ± 0.40
  Predicted FEV~1~ (L)                                    1.03 ± 0.27    1.60 ± 0.17   2.34 ± 0.29
  FEV~1~ (% predicted)                                    96.4 ± 12.7    99.0 ± 11.8   98.5 ± 11.7
  FEV~1~ postbronchodilator (% predicted)                 104.9 ± 11.3                 103.8 ± 11.5
  ^***a***^Geometric mean (GSD).                                                       

*Exposure to pollutants.* Figures S1 and S2 (Supplemental Material) describe the distribution of the exposure estimates by pollutant and exposure time window. MEEM predicted higher PM~10~ and NO~2~ exposures during the winter than during the summer (see Supplemental Material, Figures S1 and S2), and it predicted a wider range of exposures than the lifetime model. The lifetime exposure estimates decreased from 0--1 to 10--11 years of age (see Supplemental Material, Figures S1 and S2), which most likely reflects the general decrease of PM~10~ and NO~2~ levels in the Greater Manchester area from 1996 to 2008 ([@r13]). PM~10~ and NO~2~ exposures were moderately to strongly correlated in all exposure time windows (Pearson's *r* = 0.59--0.89).

*Association between exposure to pollutants and sR~aw~.* The results of the cross-sectional analyses conducted at 3--11 years of age are shown in Supplemental Material, Table S2. Table S2 indicates a significant negative association between PM~10~ exposure during early life and sR~aw~ at 3 and 5 years. However, all other analyses showed no statistically significant associations. Furthermore, at 11 years there was no association between PM~10~ and NO~2~ exposure (MEEM) during the summer or winter and sR~aw~ ([Table 3](#t3){ref-type="table"}), and there was no association between lifetime exposure and longitudinal sR~aw~.

###### 

Results of longitudinal analyses (GEE) of longitudinal PM~10~ and NO~2~ exposure (based on the lifetime model) and lung function and cross-sectional analy­ses (multivariable linear regression) of PM~10~ and NO~2~ exposure at 10--11 years of age (based on the lifetime model or MEEM) and lung function at 11 years of age.

  Exposure metric/lung function metric                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Longitudinal exposure and lung function   Exposure at age 10--11 (lifetime model) and lung function at age 11   Winter exposure before age 11 review (MEEM) and lung function at age 11   Summer exposure before age 11 review (MEEM) and lung function at age 11                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------- ------- ----- -------------------------- ------ ----- -------------------------- ------ -----
  PM~10~ (μg/m^3^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Ln sR~aw~ (kPa/sec)^*c*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           0.009 (--0.027, 0.010)                    0.37                                                                  453                                                                       --0.007 (--0.054, 0.040)                                                  0.77    352   --0.001 (--0.011, 0.008)   0.78   315   0.001 (--0.008, 0.009)     0.90   298
  FEV~1~ (% predicted)^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          --1.37 (--2.52, --0.23)                   0.019                                                                 342                                                                       --1.13 (--3.36, 1.09)                                                     0.32    373   --0.20 (--0.65, 0.26)      0.39   334   0.07 (--0.33, 0.47)        0.73   317
  FEV~1~ after bronchodilator treatment (% predicted)^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           --3.59 (--5.36, --1.83)                   \< 0.001                                                              176                                                                       --1.71 (--3.94, 0.53)                                                     0.13    366   --0.14 (--0.61, 0.34)      0.57   327   0.15 (--0.27, 0.57)        0.48   310
  NO~2~ (μg/m^3^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Ln sR~aw~ (kPa/sec)^*c*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           --0.007 (--0.016, 0.003)                  0.16                                                                  453                                                                       0.002 (--0.020, 0.023)                                                    0.88    352   0.001 (--0.004, 0.007)     0.64   315   --0.001 (--0.006, 0.004)   0.57   298
  FEV~1~ (% predicted)^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          --0.83 (--1.39, --0.28)                   0.003                                                                 342                                                                       --0.83 (--1.79, 0.14)                                                     0.093   373   --0.10 (--0.36, 0.17)      0.47   334   0.05 (--0.18, 0.29)        0.66   317
  FEV~1~ after bronchodilator treatment (% predicted)^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           --1.20 (--1.97, --0.43)                   0.002                                                                 176                                                                       --1.00 (--1.96, --0.03)                                                   0.043   366   --0.01 (--0.29, 0.27)      0.93   327   0.08 (--0.17, 0.32)        0.53   310
  GEE, generalized estimating equation.^***a***^β coefficient per 1-μg/m^3^ increase in exposure. ^***b***^Number of children included in analysis. ^***c***^Adjusted for age, sex, concurrent body mass index, concurrent atopy, concurrent asthma or wheeze, family history of asthma, hospitalization during first two years of life for lower respiratory tract infection, average 3-day background PM~10~ concentration prior to sR~aw~ ­measurement, mean Tanner stage. ^***d***^Adjusted for age (only in GEE), concurrent atopy, concurrent asthma or wheeze, hospitalization during first two years of life for lower respiratory tract infection, gas cooker in home, mean Tanner stage.                                                                                                                                                                                                                                                                                                                                                               

*Association between exposure to pollutants and FEV~1~.* In the cross-sectional analysis at 11 years of age, there was no association between PM~10~ and NO~2~ exposure (MEEM) during the summer or winter and FEV~1~ percent predicted ([Table 3](#t3){ref-type="table"}). In contrast, the longitudinal model of lifetime exposure to pollutants and longitudinal measures of FEV~1~ revealed a significant association between exposure to pollutants and the change in this measure of lung function during childhood. PM~10~ and NO~2~ exposures were associated with poorer lung function over time \[PM~10~: β = --1.37 (95% CI: --2.52, --0.23); NO~2~: β = --0.83 (95% CI: --1.39, --0.28)\]. Based on the average predicted FEV~1~ within MAAS at 5, 8, and 11 years of 1.65 L ([Table 2](#t2){ref-type="table"}), the model estimated that for each unit increase (1 μg/m^3^) in PM~10~ exposure, the growth in FEV~1~ from 5 to 11 years was 23 mL smaller; and for each unit increase (1 μg/m^3^) of NO~2~ exposure, the growth in FEV~1~ was 14 mL smaller \[ΔFEV~1~ = β / 100 × 1.65 × 1,000\]. Results of cross-sectional analyses conducted at other time points are shown in Supplemental Material, Table S3; we observed no statistically significant association between PM~10~ or NO~2~ exposure windows and FEV~1~ in cross-sectional analyses.

*Association between exposure to pollutants and postbronchodilator FEV~1~.* At 11 years of age, there was no association between PM~10~ or NO~2~ exposure (MEEM) during the summer or winter and postbronchodilator FEV~1~ percent predicted ([Table 3](#t3){ref-type="table"}). However, there was a significant negative association between postbronchodilator FEV~1~ and the annual average NO~2~ exposure from 10 to 11 years of age estimated by the lifetime model (β = --1.00; 95% CI: --1.96, --0.03, *p* = 0.043). In the longitudinal models, we observed a significant negative association between postbronchodilator FEV~1~ and PM~10~ and NO~2~ exposure over time \[PM~10~: β = --3.59 (95% CI: --5.36, --1.83); NO~2~: β = --1.20 (95% CI: --1.97, --0.43)\]. Based on the average predicted FEV~1~ of 1.65 L, these would be equivalent to a growth deficit in post bronchodilator FEV~1~ of 59 mL from 5 to 11 years of age per unit increase in PM~10~, and a growth deficit of 20 mL from 5 to 11 years per unit increase in NO~2~. For completeness results of cross-sectional analyses conducted at other time points are shown in Supplemental Material, Table S4. Table S4 shows significant negative associations between postbronchodilator FEV~1~ and early-life PM~10~ (β~Age\ 0--1~ = --3.00; 95% CI: --5.29, --0.71; β~Age\ 0--5~ = --4.70; 95% CI: --7.85, --1.55) and NO~2~ exposures (β~Age\ 0--1~ = --0.91; 95% CI: --1.77, --0.05).

Discussion
==========

To our knowledge, this is the first study to estimate the effect of modeled individual lifetime exposure to PM~10~ and NO~2~, from birth through elementary school, on the development of lung function measured throughout childhood. With both exposure and lung function modeled longitudinally, our results indicated a small but statistically significant impairment in growth of FEV~1~ with an increase in exposure to air pollutants. We estimated the size of this effect to be a loss of 23 mL in the growth in FEV~1~ from 5 to 11 years of age per unit increase in PM~10~ (\~ 3.8 mL/year), and 14 mL per unit increase of NO~2~ exposure (\~ 2.3 mL/year). In addition, we observed significant associations of PM~10~ and NO~2~ exposures with postbronchodilator FEV~1~. In cross-sectional analyses, using a detailed assessment of summer and winter pollutant exposure at 11 years, we found no associations between air pollution and contemporaneous measures of lung function.

One of the strengths of this study was the use of the comprehensive validated MEEM model to estimate exposures for cross-sectional analyses of outcomes at 11 years of age. This model provided weighted estimates of exposure based on time--activity patterns and NO~2~ and PM~10~ models with a high spatiotemporal resolution. Ideally, we would have used MEEM to estimate lifetime exposure of each child. However, MEEM requires detailed descriptions of the house design that were not available longitudinally for the approximately 50% of children who had moved house from their original home during follow-up. Therefore we used the lifetime model---a slightly simplified version of MEEM that did not require detailed knowledge of the home environment to estimate exposures on a monthly basis from birth to 11 years for longitudinal analyses. The ranges of exposures estimated by MEEM (9.7--28.0 μg/m^3^ and 6.5--38.1 μg/m^3^ for PM~10~ during the previous summer and winter, respectively; and 9.5--43.0 μg/m^3^ and 10.3--47.2 μg/m^3^ for NO~2~, respectively) were greater than the corresponding estimates from the lifetime model at 10--11 years (PM~10~: 8.8--14.0 μg/m^3^; NO~2~: 10.8--23.7 μg/m^3^). Differences between estimates from each model reflect the different time periods used for averaging (3-month averages during summer and winter for MEEM, 12-month averages at 10--11 years of age for the lifetime model) and the use of the INDAIR model to estimate indoor exposures for MEEM, which captures peaks in exposure due to gas cooking and cigarette smoking, as well as very low exposures due to low air exchange rates. However, the lifetime model also improves over previously used exposure assessment methods by providing retrospective estimates of monthly exposures that can be aggregated into different exposure time windows for longitudinal and cross-sectional analyses. Furthermore, using home and school address histories, we modeled exposure at an individual level, rather than a community level, thereby reducing the potential for exposure misclassification.

Because of the strong correlation between NO~2~ and PM~10~ exposures in our study, we used single- rather than two-pollutant models. Many previous cohort studies of air pollution have included cigarette smoking and socioeconomic status as confounders in their analysis ([@r7]; [@r27]; [@r45]). Although it is likely that parental smoking and socioeconomic status affect lung function in children, we did not include them in our final model because they were not significant predictors of the outcomes, and we therefore assumed that they did not confound associations with air pollution exposures in our study. However, we cannot rule out residual confounding by these or other exposures. In addition, we acknowledge that our estimates of PM~10~ exposures do not necessarily represent the size fraction of particulate matter that is most damaging and that further studies of associations with fine or ultrafine particles are needed to address this.

Another strength of this study was its setting in the context of a population-based birth cohort with repeated measurements of lung function---an objective outcome that is not affected by recall or reporting bias---at four ages. Assessment of sR~aw~ enabled measurement of lung function from a young age (3 years). Assessing bronchodilator responses is a common diagnostic tool to test for reversible airway obstruction that can also be used to estimate the maximum achievable expiratory volume of a child. The results of our longitudinal analyses suggest an average annual growth deficit of 9.8 mL/year and 3.3 mL/year in the maximum achievable expiratory volume with each unit increase in PM~10~ and NO~2~ exposure.

A limitation of this study was the relatively small sample sizes for some of the analyses, mostly due to missing exposure data. Exposure data were missing for children who moved outside the Greater Manchester area and for children with incomplete information on home and school addresses. However, the loss in precision due to sample size limitations may be partly offset by the use of detailed individual-level estimates of longitudinal exposures.

Most published studies have investigated the association between pollutant exposure and FEV~1~ cross-sectionally---at a single time point only. Some of these studies also reported that PM~10~ or NO~2~ exposures were associated with decreases in mean FEV~1~, but not at a statistically significant level ([@r2]; [@r17]; [@r36]). However, other studies have reported significant negative associations between air pollution exposure and FEV~1~ ([@r18], [@r19]; [@r24]; [@r38]; [@r41]), but often only in subgroups of children \[e.g., only in girls ([@r38]), only in one age group ([@r19]), or only during one season ([@r24])\].

Few studies have estimated the longitudinal effects of pollutants on the growth in lung function ([Table 4](#t4){ref-type="table"}). The Children's Health Study was set in 12 communities of Southern California (USA), with a broad range of pollutant exposures ([@r18], [@r19]). After 4 years of follow-up from 10 years of age, increasing community exposure to PM~10~ was associated with a reduced adjusted mean FEV~1~ growth rate, with those in the most polluted community having an estimated cumulative reduction in FEV~1~ of 3.4% over 4 years compared with those in the least polluted communities ([@r18]). After 8 years of follow-up, this association with PM~10~ was no longer statistically significant, although a much higher proportion of the children who lived in high-PM~10~ communities had a FEV~1~ \< 80% predicted. By the time children were 18 years of age, the average FEV~1~ in the community with the highest NO~2~ exposure was about 100 mL lower than that seen in the community with the lowest exposure ([@r19]). In a population of 975 8-year-old Austrian children who were followed for 3 years, significant negative associations with lung function growth were reported for winter NO~2~ and summer PM~10,~ even though higher concentrations of PM~10~ were present during the winter ([@r24]). A 3-year study of 3,170 children living in Mexico City, which has comparatively high pollution levels, reported statistically significant negative associations of both PM~10~ and NO~2~ with growth in FEV~1~ ([@r41]). Specifically, the authors estimated that an interquartile range (IQR) increase in PM~10~ (36.4 μg/m^3^) was associated with a mean annual deficit in FEV~1~ of 29 mL in girls and 27 mL in boys. Similarly, they estimated that an IQR increase in NO~2~ (12.0 ppb) was associated with a mean annual deficit of 32 mL in girls and 26 mL in boys. When estimates are scaled to the same exposure increment and time period ([Table 4](#t4){ref-type="table"}), it is apparent that past and present longitudinal studies have estimated a very broad range of effect sizes on lung function growth.

###### 

Comparison of average deficit in lung growth with findings from previously published population-based studies.

  Reference, country                                                                                                   Exposure assigned at   Study duration   Range of exposures (μg/m^3^)   Average deficit in lung growth (mL/year) associated with 1-μg/m^3^ increase in exposure^*a*^                               
  -------------------------------------------------------------------------------------------------------------------- ---------------------- ---------------- ------------------------------ ---------------------------------------------------------------------------------------------- --------------------------- -------------------------
  Gauderman et al. 2000, 2004, USA                                                                                     Community level        Age 10--14       20--65                         10--70                                                                                         0.20                        0.19
  Horak et al. 2002, Austria                                                                                           Community level        Age 8--11        9--31                          2--35                                                                                          8.4                         9.5
  Rojas-Martinez et al. 2007, Mexico                                                                                   Community level        Age 8--11        53--96                         54--74                                                                                         0.80 (girls), 0.74 (boys)   1.4 (girls), 1.1 (boys)
  Present study, United Kingdom                                                                                        Individual level       Birth--age 11    10--16                         15--28                                                                                         3.8                         2.3
  ^***a***^Calculated based on published figures, assuming a linear relationship between exposure and lung function.                                                                                                                                                                                                     

Having found a longitudinal association during childhood, we find it interesting to speculate at which time point exposure to pollutants may be most damaging to lung function. The cross-sectional analysis of the detailed NO~2~ and PM~10~ exposure estimates derived from MEEM showed no association between exposure and lung function at 11 years of age. However, for postbronchodilator FEV~1~ the cross-sectional analyses indicate that early exposures are associated with poorer lung function (see Supplemental Material, Table S4), but this association was not as evident for FEV~1~ percent predicted (see Supplemental Material, Table S3). Previous research has suggested that lung development during infancy is particularly susceptible to environmental toxins and that exposure can result in irreversible lung damage ([@r14]; [@r39]). In the Children's Health Study, no significant associations of pollutant exposures were reported for older children (recruited at 13 and 15 years of age) who were also followed longitudinally ([@r18]). However, most epidemiological studies on children's lung function have assessed only present air pollution exposure ([@r20]), and very little work has been done on early-life exposure ([@r36]). The results of the present study support the hypothesis that early life exposures may affect lung development in later life.

We found evidence of an impairment in lung function growth at apparently lower exposure levels than those of previous longitudinal studies of air pollution exposure and lung function in children ([@r2]; [@r19]; [@r41]). However, exposure estimates in previous studies are not directly comparable with exposure estimates used in our study, because they were based on levels measured at centrally located outdoor pollution monitors. In contrast, our estimates accounted for both indoor and outdoor exposures, because children living in urban areas in industrialized countries spend most of their time indoors ([@r25]). Our previous work on MEEM has shown that a model allowing for indoor and outdoor exposure provides a better estimate of personal exposure than methods based solely on outdoor air pollution, which tended to overestimate personal exposure ([@r32]). Therefore, it is possible that exposure levels assigned to children in previous studies based on outdoor monitors overestimated their true personal exposures. Nonetheless, the maximum outdoor concentrations of 70--80 μg/m^3^ NO~2~ and 60--90 μg/m^3^ PM~10~ found in previous studies in Mexico ([@r41]) and the United States ([@r2]; [@r19]) do exceed the current regulatory limits for annual mean concentrations in the United Kingdom (NO~2~ = 40 μg/m^3^; PM~10~ = 40 μg/m^3^) and are higher than concentrations typically measured at urban background monitoring stations in Manchester ([@r30], [@r31]).

Conclusions
===========

Our findings suggest that lifetime exposure to PM~10~ and NO~2~ may be associated with reduced growth in FEV~1~ in children. Although the observed reductions in FEV~1~ growth were small, and therefore may have little impact on healthy individuals, they could have implications for individuals with chronic respiratory disease, particularly obstructive lung diseases, or in children who go on to smoke cigarettes. Future follow-up will provide further insight on whether reductions in FEV~1~ growth associated with air pollution persist into adulthood or disappear during adolescence.

Supplemental Material
=====================

###### 

Click here for additional data file.
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